Facebook Pixel
Wishlist

Swisse-Evening Primrose Oil 200 Capsules

Regular Price: $39.99

Special Price: $21.99

Total Sold: 91

Availability: In stock

A supplement that provides premenstrual support for women!



  • Has anti-inflammatory properties.

  • Aids in maintaining overall good health.

  • Helps boost skin health.

Description

Product Description

Swisse Ultiboost Evening Primrose Oil is a premium quality formula to provide premenstrual support for women, help maintain healthy skin and support general health and wellbeing.

Swisse Ultiboost Evening Primrose Oil is a rich source of GLA, a long-chain fatty acid that may help with inflammation.
Research suggests that women with PMS may have low levels of GLA. Evening primrose oil is a source of GLA. GLA helps support women during the premenstrual period. Evening Primrose Oil contains GLA to help maintain the appearance of healthy skin and can help assist with dryness and itching
associated with mild skin conditions.

Swisse Ultiboost Evening Primrose Oil has been formulated based on scientific evidence to help support the health of women.

 

Active Ingredients

Each Capsule Contains:
Evening Primrose Oil 1 g (equiv. gamma-Linolenic acid 100 mg)

** No added gluten, lactose, egg, yeast, preservatives and artificial flavours.

 

Directions For Use

One capsule, three times daily or as directed by a healthcare professional.

 

Warning

Always read the label.

Use only as directed.

If symptoms persist, see your healthcare practitioner.

 

About Swisse

Swisse is an Australian success story. It all began with founder Kevin Ring in a humble Melbourne warehouse in 1969. From the outset, our mission was embedded in the Swisse DNA – a dream to make people all over the world healthier and happier. Today, the Swisse product range stretches from top selling men’s and women’s multivitamins and dietary supplements, to sports nutrition, skincare and functional foods. Swisse products are currently available in Australia, New Zealand, China, Singapore, the UK, Italy and the Netherlands, with plans to launch in up to 30 countries in the next five years.